mcrb: the income statement

MyFinsight

Seres Therapeutics, Inc. (MCRB)

For the quarter ending 2025-06-30, MCRB made $5,026K in revenue. -$19,855K in net income. Net profit margin of -395.05%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Net (loss) from discontinuing operations, net of tax	-
Research and development expenses	12,939
General and administrative expenses	10,253
Manufacturing services	1,689
Total operating expenses	24,881
Loss from operations	-24,881
Other income	4,295
Interest income	546
Interest expense	-
Gain on sale of vowst business	185
Total other income, net	5,026
Net income (loss) from continuing operations	-19,855
Net income (loss)	-19,855

Net loss per share attributable to common stockholders - basic	-2.27
Net loss per share attributable to common stockholders - diluted	-2.27
Weighted average number of shares outstanding, diluted	8,743,733
Weighted-average shares outstanding - basic	8,743,733

Unit: Thousand (K) dollars (except for numbers of shares and EPS)